Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae
- PMID: 12499172
- PMCID: PMC148977
- DOI: 10.1128/AAC.47.1.77-81.2003
Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae
Abstract
The inhibitory activities (50% inhibitory concentrations [IC(50)s]) of gatifloxacin and other quinolones against both DNA gyrase and topoisomerase IV of the wild-type Streptococcus pneumoniae IID553 were determined. The IC(50)s of 10 compounds ranged from 4.28 to 582 microg/ml against DNA gyrase and from 1.90 to 35.2 microg/ml against topoisomerase IV. The inhibitory activity against DNA gyrase was more varied than that against topoisomerase IV among fluoroquinolones. The IC(50)s for DNA gyrase of the 8-methoxy quinolones gatifloxacin and AM-1147 were approximately seven times lower than those of their 8-H counterparts AM-1121 and ciprofloxacin, whereas the IC(50)s for topoisomerase IV were 1.5 times lower. Moreover, the IC(50) ratios (IC(50) for DNA gyrase/IC(50) for topoisomerase IV) of gatifloxacin, AM-1147, and moxifloxacin, which possess 8-methoxy groups, were almost the same. The 8-methoxy quinolones showed higher antibacterial activity and less mutant selectivity against IID553 than their 8-H counterparts. These results suggest that the 8-methoxy group enhances both target inhibition, especially for DNA gyrase, leading to potent antipneumococcal activity and dual inhibition against both DNA gyrase and topoisomerase IV in the bacterial cell.
Similar articles
-
Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae.Antimicrob Agents Chemother. 2001 Jun;45(6):1649-53. doi: 10.1128/AAC.45.6.1649-1653.2001. Antimicrob Agents Chemother. 2001. PMID: 11353607 Free PMC article.
-
Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.Antimicrob Agents Chemother. 2002 Feb;46(2):413-9. doi: 10.1128/AAC.46.2.413-419.2002. Antimicrob Agents Chemother. 2002. PMID: 11796351 Free PMC article.
-
Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.Antimicrob Agents Chemother. 1998 Oct;42(10):2678-81. doi: 10.1128/AAC.42.10.2678. Antimicrob Agents Chemother. 1998. PMID: 9756776 Free PMC article.
-
Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claims.J Antimicrob Chemother. 2002 Jun;49(6):893-5. doi: 10.1093/jac/dkf047. J Antimicrob Chemother. 2002. PMID: 12039880 Review. No abstract available.
-
[Antibacterial property and clinical effect of gatifloxacin, a novel quinolone antibacterial agent].Nihon Yakurigaku Zasshi. 2003 Jun;121(6):447-56. doi: 10.1254/fpj.121.447. Nihon Yakurigaku Zasshi. 2003. PMID: 12835539 Review. Japanese.
Cited by
-
Gatifloxacin: a review of its use in the treatment of bacterial infections in the US.Drugs. 2005;65(5):695-724. doi: 10.2165/00003495-200565050-00007. Drugs. 2005. PMID: 15748100 Review.
-
Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities.Antibiotics (Basel). 2017 Nov 7;6(4):26. doi: 10.3390/antibiotics6040026. Antibiotics (Basel). 2017. PMID: 29112154 Free PMC article. Review.
-
Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.Antimicrob Agents Chemother. 2013 Apr;57(4):1772-6. doi: 10.1128/AAC.01956-12. Epub 2013 Jan 28. Antimicrob Agents Chemother. 2013. PMID: 23357772 Free PMC article.
-
Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniae.Antimicrob Agents Chemother. 2015 Nov 2;60(1):409-17. doi: 10.1128/AAC.02299-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26525786 Free PMC article.
-
Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones-Shaping the Fifth Generation.Pharmaceutics. 2021 Aug 18;13(8):1289. doi: 10.3390/pharmaceutics13081289. Pharmaceutics. 2021. PMID: 34452252 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources